These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30160917)
1. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Hyperuricemia and Gout]. Yamanaka H Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):2039-45. PubMed ID: 30160917 [No Abstract] [Full Text] [Related]
2. [Hyperuricemia. When and how to treat?]. Reuss-Borst MA Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735 [TBL] [Abstract][Full Text] [Related]
3. Update on gout and hyperuricemia. Baker JF; Schumacher HR Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378 [TBL] [Abstract][Full Text] [Related]
4. Japanese guideline for the management of hyperuricemia and gout: second edition. Yamanaka H; Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1018-29. PubMed ID: 22132951 [TBL] [Abstract][Full Text] [Related]
5. The year in gout: 2011-2012. Crittenden DB; Pillinger MH Bull NYU Hosp Jt Dis; 2012; 70(3):145-51. PubMed ID: 23259621 [TBL] [Abstract][Full Text] [Related]
6. [Hyperuricemia and gout]. Gröbner W Dtsch Med Wochenschr; 2015 Oct; 140(21):1615-26. PubMed ID: 26488103 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of hyperuricemia and gout]. Kamatani N Nihon Naika Gakkai Zasshi; 2007 Mar; 96(3):510-4. PubMed ID: 17419418 [No Abstract] [Full Text] [Related]
8. Are hyperuricemia and gout different diseases? Comment on the guidelines for the diagnosis and management of hyperuricemia and gout with the healthcare professional perspectives in China. Li Y; Lin Z; Wang Y; Wu H; Zhang B Int J Rheum Dis; 2023 Sep; 26(9):1866-1868. PubMed ID: 36719050 [No Abstract] [Full Text] [Related]
9. [Hyperuricemia/gout]. Peuke C Med Monatsschr Pharm; 2010 Nov; 33(11):429-32. PubMed ID: 21166253 [No Abstract] [Full Text] [Related]
10. Gout: what primary care physicians want to know. Dore RK J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S47-54. PubMed ID: 18830091 [TBL] [Abstract][Full Text] [Related]
12. [Austrian 3e-recommendations for diagnosis and management of gout 2013]. Sautner J; Gruber J; Herold M; Zwerina J; Leeb BF Wien Klin Wochenschr; 2014 Feb; 126(3-4):79-89. PubMed ID: 24297266 [TBL] [Abstract][Full Text] [Related]
13. Current and future therapeutic options for the management of gout. Whelton A Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597 [TBL] [Abstract][Full Text] [Related]
14. [Hyperuricemia and gout; the role of diet]. Álvarez-Lario B; Alonso-Valdivielso JL Nutr Hosp; 2014 Apr; 29(4):760-70. PubMed ID: 24679016 [TBL] [Abstract][Full Text] [Related]
15. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout. Kamatani N; Hosoya T J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264 [No Abstract] [Full Text] [Related]
16. Febuxostat--treatment for hyperuricemia and gout? Moreland LW N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099 [No Abstract] [Full Text] [Related]
19. Hyperuricemia and Gout in Orthopaedics. Meller M; Epstein A; Meller AY; Osmani FA; Parekh A; Chuang D; Gonzalez M JBJS Rev; 2018 Oct; 6(10):e11. PubMed ID: 30376463 [No Abstract] [Full Text] [Related]
20. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. Ernst ME; Fravel MA Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]